Home › Myasthenia Gravis › District of Columbia › Washington
Myasthenia Gravis clinical trials in Washington, DC
6 studies for Myasthenia Gravis are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Feasibility of Remote Monitoring of Patients With Myasthenia Gravis
RecruitingObservational study
- The George Washington University, Washington D.C.
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
RecruitingPhase 3
- The George Washington University Medical Faculty Associates Foggy Bottom South Pavilion, Washington D.C.
MuSK Myasthenia 1000 Study
RecruitingObservational study
- George Washington University, Washington D.C.
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
RecruitingPhase 3
- Site Number - 1024, Washington D.C.
PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
RecruitingPhase 3
- Research Site, Washington D.C.
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
RecruitingObservational study
- Clinical Trial Site, Washington D.C.
About Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune disease that weakens the muscles under your control. Find out about MG causes, symptoms, and treatment.
More about Myasthenia Gravis on MedlinePlus
Myasthenia Gravis trials in other cities
- Tampa, FL12 studies
- Houston, TX11 studies
- Durham, NC10 studies
- Boca Raton, FL10 studies
- Columbus, OH8 studies
- Miami, FL7 studies
- New York City, NY7 studies
- Milwaukee, WI7 studies
- St. Louis, MO7 studies
- Boston, MA6 studies
- San Francisco, CA6 studies
- Portland, OR6 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.